Stock Valuation / CI
Is The Cigna Group (CI) Overvalued? Fair Value & 5-Year Target
The Cigna Group trades at $282.53 (P/E 11.69). Our reference model estimates a fair value of $322.27 at its recent average P/E of 13.33.
| Current price | $282.53 |
|---|---|
| Current EPS | $24.17 |
| Current P/E | 11.69 |
| Average P/E | 13.33 |
| Fair value (at avg P/E) | $322.27 |
| Upside to fair value | +14.1% |
| Illustrative 5-yr target (25× P/E, 15% growth) | $1,215.36 |
What drives CI's valuation
Changing either assumption moves the target: a higher P/E multiple or faster EPS growth raises fair value, a lower multiple or slower growth lowers it. The interactive dashboard lets you edit both and re-run the model instantly.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. He
Frequently asked questions
What is CI's fair value?
At its recent average P/E of 13.33, The Cigna Group (CI) has a reference fair value of about $322.27, which is +14.1% versus the current price of $282.53.
Is The Cigna Group (CI) overvalued or undervalued?
Based on the average-P/E reference model, The Cigna Group looks undervalued relative to fair value by roughly +14.1%. This is a model output, not investment advice — change the P/E and growth assumptions in the dashboard for your own view.
What is a 5-year price target for CI?
Under an illustrative model of 25× P/E and 15% annual EPS growth, the implied 5-year target is $1,215.36. Adjust both inputs on the interactive page to match your assumptions.
Open the interactive CI valuation dashboard →
Figures are for informational purposes only and are not investment advice. Data as of 2026-10-14.